PALIPERIDONE FOR THE TREATMENT OF KETAMINE-INDUCED PSYCHOSIS: A CASE REPORT

被引:4
作者
Zuccoli, M. L. [1 ]
Muscella, A. [2 ]
Fucile, C. [1 ]
Carrozzino, R. [3 ]
Mattioli, F. [1 ]
Martell, A. [1 ]
Orengo, S. [2 ]
机构
[1] Univ Genoa, I-16132 Genoa, Italy
[2] San Paolo Hosp, Savona, Italy
[3] Correct Hlth Serv ASL2 Savonese, Savona, Italy
关键词
paliperidone; ketamine; psychosis; drug abuse; METHYL-D-ASPARTATE; PREFRONTAL CORTEX; NONMEDICAL USE; DOPAMINE; PHENCYCLIDINE; METABOLISM; RECEPTORS; GLUTAMATE; RELEASE; BRAIN;
D O I
10.2190/PM.48.2.c
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Ketamine is an anaesthetic and analgesic drug synthesized in the 1960s from phencyclidine. The recreational use of ketamine increased among the dance culture of techno and house music, in particular in clubs, discotheques, and rave parties. The psychotropic effects of ketamine are now well known and they range from dissociation to positive, negative, and cognitive schizophrenia-like symptoms. We report a case of a chronic oral consumption of ketamine which induced agitation, behavioral abnormalities, and loss of contact with reality in a poly-drug abuser; these symptoms persisted more than two weeks after the drug consumption had stopped. Antipsychotic treatment with paliperidone led to a successful management of the psychosis, getting a complete resolution of the clinical picture. Paliperidone has proven to be very effective in the treatment of ketamine-induced disorders. Moreover, the pharmacological action and metabolism of paliperidone are poorly dependent from the activity of liver enzymes, so that it seems to be one of the best second generation antipsychotics for the treatment of smokers and alcohol abusers.
引用
收藏
页码:103 / 108
页数:6
相关论文
共 20 条
[1]  
[Anonymous], 2009, INV PAL EXT REL TABL
[2]   GABAB/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum [J].
Balla, Andrea ;
Nattini, Megan E. ;
Sershen, Henry ;
Lajtha, Abel ;
Dunlop, David S. ;
Javitt, Daniel C. .
NEUROPHARMACOLOGY, 2009, 56 (05) :915-921
[3]   BEHAVIORAL-EFFECTS OF PHENCYCLIDINE AND KETAMINE ALONE AND IN COMBINATION WITH OTHER DRUGS [J].
BYRD, LD ;
STANDISH, LJ ;
HOWELL, LL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 144 (03) :331-341
[4]   Illicit use of ketamine in Scotland [J].
Dalgarno, PJ ;
Shewan, D .
JOURNAL OF PSYCHOACTIVE DRUGS, 1996, 28 (02) :191-199
[5]   Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia [J].
Duncan, GE ;
Moy, SS ;
Knapp, DJ ;
Mueller, RA ;
Breese, GR .
BRAIN RESEARCH, 1998, 787 (02) :181-190
[6]   Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation [J].
Duncan, GE ;
Leipzig, JN ;
Mailman, RB ;
Lieberman, JA .
BRAIN RESEARCH, 1998, 812 (1-2) :65-75
[7]   New rave drugs:: Ketamine and prolintane [J].
Gaulier, JM ;
Canal, M ;
Pradeille, JL ;
Marquet, P ;
Lachâtre, G .
ACTA CLINICA BELGICA, 2002, 57 :41-46
[8]  
Hays H, 2012, WEST J EMERG MED, V13, P536, DOI 10.5811/westjem.2012.7.12527
[9]   NONMEDICAL USE OF KETAMINE [J].
JANSEN, KLR .
BRITISH MEDICAL JOURNAL, 1993, 306 (6878) :601-602
[10]   A review of the nonmedical use of ketamine: Use, users and consequences [J].
Jansen, KLR .
JOURNAL OF PSYCHOACTIVE DRUGS, 2000, 32 (04) :419-433